How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

1,339 results for

Pediatric Auditory Screening

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

181. Autism and PDD - Management for child or teenager

Autism and PDD - Management for child or teenager QUICK REFERENCE GUIDE Autism and other PDDs 1 Coordinated education and treatment interventions in children and adolescents Coordinated education and treatment interventions in children and adolescents March 2012 March 2012 INVOLVE THE CHILD OR ADOLESCENT AND PARENTS – PAY ATTENTION TO SIBLINGS Children and adolescents have rights. They should be treated with dignity and their history, personality, routines, own wishes and tastes, abilities (...) be offered. C ? For children or adolescents who rarely communicate orally, alternative or augmentative communication tools should be used as soon as possible and consistently across different environments. EVALUATE THE CHILD OR ADOLESCENT’S DEVELOPMENT REGULARLY The purpose of evaluating the child or adolescent’s development and health is to define and adjust the interventions offered to him or her within the context of a personalised care plan and to ensure that this plan is consistent with up-to-date

2012 HAS Guidelines

182. Incidental learning in a multisensory environment across childhood Full Text available with Trip Pro

Incidental learning in a multisensory environment across childhood Multisensory information has been shown to modulate attention in infants and facilitate learning in adults, by enhancing the amodal properties of a stimulus. However, it remains unclear whether this translates to learning in a multisensory environment across middle childhood, and particularly in the case of incidental learning. One hundred and eighty-one children aged between 6 and 10 years participated in this study using (...) a novel Multisensory Attention Learning Task (MALT). Participants were asked to respond to the presence of a target stimulus whilst ignoring distractors. Correct target selection resulted in the movement of the target exemplar to either the upper left or right screen quadrant, according to category membership. Category membership was defined either by visual-only, auditory-only or multisensory information. As early as 6 years of age, children demonstrated greater performance on the incidental

2017 Developmental science

183. Advancing Child Competencies by Extending Supported Services (ACCESS) for Families Program

Checklist, Ages 1.5-5 (CBCL, 1.5-5) [ Time Frame: Change from Week 0, Week 8, Week 21, Week 42 and Week 68 ] The Child Behavior Checklist 1.5-5 (CBCL/1.5-5; Achenbach & Rescorla, 2001) is a 99-item caregiver- report questionnaire of behavioral, emotional, and social problems in children between the ages of 18 months and 5 years. In the current study the externalizing behavior problem scale will be used to screen children into the study (T- score = 60), and the following subscales will be used (...) , Week 8, Week 21, Week 42 and Week 68 ] The Sutter-Eyberg Student Behavior Inventory-Revised (SESBI-R; Eyberg & Pincus, 1999) is a teacher rating scale of disruptive behaviors at school in children as young as 2 years, and the Intensity and Problem scales will be used as outcome measures for participants in school to assess generalization of improvement in child disruptive behavior to the classroom setting. Multidimensional Assessment of Preschool Disruptive Behavior (MAP-DB): Temper Loss Scale

2017 Clinical Trials

184. The Effect of Amblyopia on Visual-Auditory Speech Perception: Why Mothers May Say "Look At Me When I'm Talking To You" Full Text available with Trip Pro

The Effect of Amblyopia on Visual-Auditory Speech Perception: Why Mothers May Say "Look At Me When I'm Talking To You" Children with a history of amblyopia, even if resolved, exhibit impaired visual-auditory integration and perceive speech differently.To determine whether a history of amblyopia is associated with abnormal visual-auditory speech integration.Retrospective observational study at an academic pediatric ophthalmologic clinic with an average of 4 years of follow-up. Participants were (...) at least 3 years of age and without any history of neurologic or hearing disorders. Of 39 children originally in our study, 6 refused to participate. The remaining 33 participants completed the study. Twenty-four participants (mean [SD] age, 7.0 [1.5] years) had a history of amblyopia in 1 eye, with a visual acuity of at least 20/20 in the nonamblyopic eye. Nine controls (mean [SD] age, 8.0 [3.4] years) were recruited from referrals for visually insignificant etiologies or through preschool-screening

2014 JAMA ophthalmology

185. Auditory Outcome After Cochlear Implantation in Patients With Congenital Nonsyndromic Hearing Loss: Influence of the GJB2 Status. (Abstract)

Auditory Screening Procedure), and others. Follow-up period was at least 36 months.Mean test scores were compared at the 1st, 6th, 12th, 24th, and 36th month. LiP outcome was significantly better (p < 0.05) for the GJB2-related cohort for the whole follow-up period except at the first month. MTP3, 6, and 12 tests displayed the same statistically significant outcome in favor of the first group. In the open-set test GASP, the difference was apparent: 1.22, 2.40, 5.59, and 7.40 mean scores at the 6th (...) , 12th, 24, and 36th months for the first cohort versus 0.00, 0.07, 0.81, and 1.74 for the GJB2-unrelated patients.The results from our study suggest that children with GJB2-related deafness show better auditory performance after cochlear implantation than age-matched children with GJB2-nonrelated sensorineural hearing loss.

2014 Otology and Neurotology

186. Analysis of click-evoked auditory brainstem responses using time domain cross-correlations between interleaved responses. (Abstract)

Analysis of click-evoked auditory brainstem responses using time domain cross-correlations between interleaved responses. The rapidly evolving field of early diagnostics after the introduction of newborn hearing screening requires rapid, valid, and objective methods, which have to be thoroughly evaluated in adults before use in infants. The aim was to study cross-correlation analysis of interleaved auditory brainstem responses (ABRs) in a wide dynamic range in normal-hearing adults. Off-line

2014 Ear and hearing

187. Reflectance Measures from Infant Ears with Normal Hearing and Transient Conductive Hearing Loss. (Abstract)

Reflectance Measures from Infant Ears with Normal Hearing and Transient Conductive Hearing Loss. The objective is to develop methods to utilize newborn reflectance measures for the identification of middle-ear transient conditions (e.g., middle-ear fluid) during the newborn period and ultimately during the first few months of life. Transient middle-ear conditions are a suspected source of failure to pass a newborn hearing screening. The ability to identify a conductive loss during the screening (...) procedure could enable the referred ear to be either (1) cleared of a middle-ear condition and recommended for more extensive hearing assessment as soon as possible, or (2) suspected of a transient middle-ear condition, and if desired, be rescreened before more extensive hearing assessment.Reflectance measurements are reported from full-term, healthy, newborn babies in which one ear referred and one ear passed an initial auditory brainstem response newborn hearing screening and a subsequent distortion

2016 Ear and hearing

188. SELECTIVE DEVELOPMENTAL ALTERATIONS IN THE HIV-1 TRANSGENIC RAT: OPPORTUNITIES FOR DIAGNOSIS OF PEDIATRIC HIV-1 Full Text available with Trip Pro

SELECTIVE DEVELOPMENTAL ALTERATIONS IN THE HIV-1 TRANSGENIC RAT: OPPORTUNITIES FOR DIAGNOSIS OF PEDIATRIC HIV-1 Since the advent of combination antiretroviral therapy (cART), pediatric HIV-1 (PHIV) has evolved from a fatal disease to a chronic disease as children perinatally infected with HIV-1 survive into adulthood. The HIV-1 transgenic (Tg) rat, which expresses 7 of the 9 HIV-1 genes constitutively throughout development, was used to model the early development of chronic neurological (...) provide an opportunity for the development of a point-of-care screening tool, which would permit the early diagnosis of PHIV and improve the long-term outcome for children perinatally infected with HIV-1.

2016 Journal of neurovirology

189. Trial on Safety and Efficacy of Velmanase Alfa Treatment in Pediatric Patients With Alpha-Mannosidosis

Trial on Safety and Efficacy of Velmanase Alfa Treatment in Pediatric Patients With Alpha-Mannosidosis Trial on Safety and Efficacy of Velmanase Alfa Treatment in Pediatric Patients With Alpha-Mannosidosis - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please (...) remove one or more studies before adding more. Trial on Safety and Efficacy of Velmanase Alfa Treatment in Pediatric Patients With Alpha-Mannosidosis (rhLaman-08) The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT02998879 Recruitment Status : Active, not recruiting First Posted : December 21, 2016 Last

2016 Clinical Trials

190. Optimizing Treatment to Improve TBM Outcomes in Children

outcomes among children ages 6 months to 6 years of age who are treated for TBM, longitudinally over 18 months, by treatmentArm, as measured by the Mullen Gross Motor Scale [ Time Frame: 72 weeks ] The Gross Motor Scale is used to assess infants who are 33 months of age or younger and provides information about the child's kinesthetic experience. Maximum Raw Scores of Gross Motor Scale: 36 Raw scores are converted to T Scores (A type of standardized score) based on the child's age. A T Score has a mean (...) in Children (TBM-KIDS) The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. of clinical studies and talk to your health care provider before participating. Read our for details. ClinicalTrials.gov Identifier: NCT02958709 Recruitment Status : Recruiting First Posted : November 8, 2016 Last Update Posted : August 8, 2018 See Sponsor: Johns Hopkins University

2016 Clinical Trials

191. LearningRx Brain Training for Children 8-14

LearningRx Brain Training for Children 8-14 LearningRx Brain Training for Children 8-14 - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. LearningRx Brain Training for Children 8-14 The safety and scientific (...) to Brief Summary: The purpose of this study is to examine changes in multiple cognitive skills after completing 60 hours of cognitive training with ThinkRx, a LearningRx program. Condition or disease Intervention/treatment Phase Learning Problems Behavioral: LearningRx cognitive training Not Applicable Detailed Description: In a two-phase randomized controlled study, investigators will examine the effects of a one-on-one cognitive training program on memory, visual and auditory processing, processing

2016 Clinical Trials

192. Investigating Phenotypic Profiles of Children and Adolescents With ASD

on using eye-tracking, touch screen and electrophysiology technology (EEG), parent-report measures and parent-child interaction measures. The eye-tracking and touch screen assessments will target receptive language, word learning mechanisms, and social attention deployment to visual and auditory stimuli. The EEG/ERP assessments will target auditory processing and organization, with specific focus on mismatch negativity (MMN) markers of auditory processing. Based on these comprehensive assessments (...) Investigating Phenotypic Profiles of Children and Adolescents With ASD Investigating Phenotypic Profiles of Children and Adolescents With ASD - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Investigating

2016 Clinical Trials

193. Game-Based Rehabilitation Platform for Children With Neurodevelopmental Disorders and Acquired Brain Injuries

impairments and fine motor control abnormalities along with mild-moderate cognitive impairment. Exclusion Criteria: Child with visual impairment. Auditory impairment Orthopedic conditions such as recent fractures, fixed deformities of upper limb Any surgical intervention 6 months before the study or who intended to receive within the period of study. Non willing parents. Tools For screening: Manual Ability Classification System (MACS) (Scores: Level 2, 3 and 4) Gross Motor Function Classification Scale (...) . Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Layout table for eligibility information Ages Eligible for Study: 4 Years to 11 Years (Child) Sexes Eligible for Study: All Accepts Healthy Volunteers: No Criteria Inclusion Criteria: Children with Cerebral Palsy Age between 4-11 years Moderate upper extremity

2016 Clinical Trials

194. Testing a Novel Speech Intervention in Minimally Verbal Children With Autism Spectrum Disorder (ASD)

children with ASD and compare the two interventions to determine whether one is more effective than the other, this study also aims to examine whether baseline cognitive skills, speech praxis, joint attention abilities and/or neural architecture can predict the effects of treatment with AMMT or SRT in minimally verbal children with ASD. Condition or disease Intervention/treatment Phase Autism Behavioral: Auditory-Motor Mapping Training Behavioral: Speech-Repetition Therapy Phase 2 Phase 3 Detailed (...) Description: The ability to communicate verbally is considered the most important prognostic indicator for children with ASD. If a child has not developed speech by age 5, it is generally considered unlikely that he or she will do so. Although a small number of cases of speech development in older children with ASD have been reported, the type and intensity of treatments used varied widely, suggesting little consensus regarding the likely mechanisms involved. A few preliminary studies have tested

2016 Clinical Trials

195. Vinblastine +/- Bevacizumab in Children With Unresectable or Progressive Low Grade Glioma (LGG)

First Posted : July 21, 2016 Last Update Posted : November 6, 2018 See Sponsor: The Hospital for Sick Children Collaborator: Hoffmann-La Roche Information provided by (Responsible Party): Ute Bartels, The Hospital for Sick Children Study Details Study Description Go to Brief Summary: This is an open-label, randomized, multi-center, comparator Phase II trial looking at the addition of Bevacizumab to Vinblastine in chemotherapy naïve pediatric patients with progressive Low Grade Glioma aged 6 months (...) ] Domains include: working memory, executive function, processing speed, episodic memory, and attention To determine the effects of Bevacizumab on cognitive function in the pediatric population using the NIH Toolbox Cognitive Battery. [ Time Frame: During treatment, 28 days after completing treatment, at 6 months and 1 year off therapy ] The effects of Bevacizumab on cognitive function in the pediatric To determine if the prevalence of QOL difficulties in children and adolescents treated for LGG at 1

2016 Clinical Trials

196. Role of Ethnicity and Environment on Regulation of Response Towards Sensory Stimulation in Children

the original English version and Chinese versions of the Sensory Profile are identified and matched. Temperament: English and Chinese versions of the Temperament in Middle Child Questionnaire and Early Adolescent Temperament Questionnaire [ Time Frame: Day 1 ] Temperament will be measured using the Temperament in Middle Childhood Questionnaire (TMCQ; Simonds & Rothbart, 2004; 2006) for 7-10 year old children; and the Early Adolescent Temperament Questionnaire (TMCQ; Ellis & Rothbart, 2001) for children 11 (...) understood yet. This research aims to compare the autonomic activity at resting condition and toward a block of auditory stimulation between typically developing children from different countries and living environments. There will be two phases in this study. In Phase I, two groups of participants will be recruited: (a) 32 typically-developing Chinese children living in Hong Kong, (HK group) and (b) 32 typically developing Filipino children living in Hong Kong (Fil-HK group). In phase II, two groups

2016 Clinical Trials

197. Zika Virus Infection's Neonatal and Pediatric Consequences in French Department of America

(Guthrie's test) Cranial ultrasound Screening test for hearing capabilities by auditory evoked potentials Fundus of the eye or retinal image capture by RetCam®. Follow-up from Day 4 to 2 years: - Clinical examination focusing on neuropsychomotor development at the 2nd, 4th, 9th, 18th and 24th month. Study Design Go to Layout table for study information Study Type : Observational Estimated Enrollment : 2220 participants Observational Model: Cohort Time Perspective: Prospective Official Title: Études (...) Zika Virus Infection's Neonatal and Pediatric Consequences in French Department of America Zika Virus Infection's Neonatal and Pediatric Consequences in French Department of America - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more

2016 Clinical Trials

198. Memory and Attention in Healthy Children

Civils de Lyon Study Details Study Description Go to Brief Summary: This project studies memory and attention in healthy children aged from 5 to 17 years. The processes investigated are short term memory (auditory and visual) and attention. To characterize these processes involved in childhood, neuropsychological and neurophysiological assessments will be performed (using Electro-encephalography measures, behavioural responses and questionnaires). Condition or disease Intervention/treatment Phase (...) : Experience 3 : Visual Attention Training This experience aims at training visual attention through serious games. Children will play against an artificial intelligence and will focus their attention on one out of many possible targets (checkers, cards, boxes) presented on screen. Responses will be provided using a response-button, sometimes completed by an eye-tracking measure. Feedback will be given to the child after his response. EEG will be recorded all along to measure Neurophysiological signals

2016 Clinical Trials

199. AFQ056 for Language Learning in Children With FXS

of an auditory event-related potential (ERP) biomarker is correlated with improvement in clinical outcome markers including language and secondary outcomes Safety - Laboratory and Adverse Event Tracking [ Time Frame: Up to 21 months for each patient ] To demonstrate long-term safety and tolerability of AFQ056 in young children with FXS Cognitive. Language and Adaptive Functioning [ Time Frame: up to 21 months ] Mullen Scales of Early Learning, Preschool Language Scale, McArthur-Bates Vocabulary, Vineland (...) is to demonstrate greater improvement in language learning in young children with FXS treated with AFQ056 in combination with an intensive standardized parent-implemented language intervention, relative to those treated with the language intervention and placebo, after 6 months of intervention, as a marker of drug effect on neural plasticity, the core problem in the disorder Secondary Outcome Measures : Biomarker - Auditory Event Related Potential (ERP) [ Time Frame: up to 21 months ] To show that normalization

2016 Clinical Trials

200. Congenital Cytomegalovirus Infection and Permanent Hearing Loss in Rural North Indian Children. Full Text available with Trip Pro

-product otoacoustic emission testing. Cytomegalovirus (CMV)-positive infants and those not passing newborn hearing screening (NHS) were evaluated by auditory brainstem response to confirm PCEHL. Infants with cCMV and those with PCEHL were tested for mutations within the GJB2 gene.Of the 1720 infants screened, 40 (2.3%) did not pass NHS and 20 (1.2%) were CMV positive. Auditory brainstem evoked response testing confirmed unilateral or bilateral PCEHL in 11 (0.64%) children who either did not pass NHS (...) Congenital Cytomegalovirus Infection and Permanent Hearing Loss in Rural North Indian Children. Congenital cytomegalovirus infection (cCMV) is a leading nongenetic cause of permanent congenital or early-onset hearing loss (PCEHL). Although cCMV rates are high despite near-universal seroimmunity, the contribution of cCMV to PCEHL in the developing world is unclear.Neonates at a rural North Indian hospital were screened for cCMV by saliva polymerase chain reaction and hearing by distortion

2016 Pediatric Infectious Dsease Journal

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>